Compounding Competency — Apply competency training requirements for personnel engaged in compounding - Mpje

SECTION 1

Historical Context & Motivation

Pharmacy compounding has ancient roots, but the formal regulation of compounding personnel competency is a relatively modern development driven by patient safety crises. For centuries, pharmacists prepared individualized medications with little standardized oversight regarding the training of those who performed compounding tasks. The assumption was that a pharmacist's professional education provided sufficient preparation, but this assumption was tested as compounding grew in scale and complexity, particularly with the rise of sterile compounding in hospital and outpatient settings.

Several high-profile contamination events throughout the late twentieth and early twenty-first centuries revealed devastating gaps in compounding quality assurance, many of which were directly traceable to inadequately trained personnel. These tragedies catalyzed sweeping regulatory reforms at both the federal and state levels, establishing the competency training frameworks that pharmacy students must understand for the MPJE and for professional practice.

1997 • FDA Modernization Act (FDAMA)

Congress codified the distinction between pharmacy compounding and drug manufacturing in Section 503A, implicitly establishing that compounding required specific professional competencies beyond standard drug dispensing.

2004 • USP <797> Published

The United States Pharmacopeia issued the first enforceable standards for sterile compounding, including mandatory personnel training and competency assessment through media fill testing and gloved fingertip sampling.

2012 • NECC Meningitis Outbreak

Contaminated methylprednisolone injections from the New England Compounding Center caused 76 deaths and over 750 infections, exposing catastrophic failures in personnel competency and oversight.

2013 • Drug Quality and Security Act (DQSA)

Congress enacted the DQSA, creating Section 503B for outsourcing facilities under FDA oversight and reinforcing state board authority over 503A pharmacies, both with heightened personnel training mandates.

2023 • Revised USP <797> and New USP <795>

Major revisions to USP chapters modernized competency assessment requirements, expanded training documentation standards, and introduced formal requirements for nonsterile compounding personnel competency under USP <795>.

The central question that these regulatory milestones address is straightforward yet profoundly important: How do we ensure that every individual who touches a compounded preparation possesses the knowledge, skills, and verified competency to protect patients from harm? The answer lies in a systematic framework of initial training, ongoing assessment, and rigorous documentation that the MPJE expects you to apply across various practice scenarios.

SECTION 2

Core Principles & Definitions

Compounding competency training is built upon a regulatory architecture that spans federal law, USP standards, and state board regulations. Understanding the foundational principles requires clarity on who must be trained, what they must demonstrate, and how compliance is documented and enforced. The following core concepts form the backbone of every competency training program in pharmacy compounding.

Designated Person (DP)

Under USP standards, the Designated Person is the pharmacist or qualified individual responsible for overseeing all compounding operations, including designing and implementing the competency training program for all compounding personnel.

Compounding Personnel

This term encompasses all individuals involved in any aspect of compounding — pharmacists, pharmacy technicians, students, and anyone who enters controlled compounding areas. Each must demonstrate competency appropriate to their assigned tasks.

Initial vs. Ongoing Competency

Training is not a one-time event. Personnel must complete initial competency assessment before compounding independently, followed by periodic reassessment at defined intervals (e.g., every 6 or 12 months depending on the compounding category).

Aseptic Technique Qualification

For sterile compounding under USP <797>, personnel must pass media fill testing and gloved fingertip and thumb sampling to demonstrate that they can compound without introducing microbial contamination.

Documentation Requirements

All training activities, competency assessments, and corrective actions must be documented and maintained as part of the pharmacy's quality assurance records. State boards of pharmacy and accrediting bodies may inspect these records during routine or for-cause inspections.

✦

KEY TAKEAWAY

Think of compounding competency training like a pilot's certification program. A pilot doesn't just learn to fly once — they undergo initial training, pass practical check rides (analogous to media fill tests), and must regularly recertify. Similarly, compounding personnel must demonstrate and re-demonstrate their skills at defined intervals, and every assessment is logged in a permanent record. Just as an airline cannot let an uncertified pilot fly passengers, a pharmacy cannot permit untrained or unassessed personnel to compound medications for patients.

SECTION 3

Visual Explanation — Competency Training Framework

The competency training process follows a cyclical framework that begins with didactic education and progresses through practical demonstration, formal assessment, and documented re-evaluation. The diagram below illustrates how each stage feeds into the next, creating a continuous quality improvement loop that protects both patients and pharmacy operations.

The competency training cycle shows six interconnected stages overseen by the Designated Person. Note the feedback loop: personnel who fail any competency assessment must undergo retraining before being authorized to compound, and all personnel must be periodically reassessed even after initial authorization.

As the diagram demonstrates, compounding competency is not a linear process but rather a continuous cycle. The Designated Person bears ultimate responsibility for ensuring that each phase is executed rigorously and that documentation accompanies every step. State boards of pharmacy frequently cite failure to maintain current competency records as a basis for disciplinary action, making this cycle both a patient safety imperative and a legal compliance requirement.

SECTION 4

Mechanism — USP Standards and Federal/State Requirements

The regulatory framework governing compounding competency operates at three interlocking levels: federal statute (primarily the DQSA), national standards (USP chapters), and state pharmacy practice acts. Understanding how these layers interact is essential for MPJE preparation because exam questions frequently test your ability to identify which standard applies and what it requires in specific scenarios.

USP <797>: Sterile Compounding Personnel Requirements

Under USP <797>, all personnel who prepare compounded sterile preparations (CSPs) must complete training that covers: proper hand hygiene procedures, garbing and gowning techniques, aseptic manipulation skills, achieving and maintaining ISO Class 5 conditions in the primary engineering control (PEC), proper use of the PEC (e.g., laminar airflow workbench, compounding aseptic isolator), cleaning and disinfection of compounding areas, and the principles behind beyond-use dating. Competency assessment for sterile compounding specifically requires successful completion of media fill testing (also called process simulation), in which the compounder prepares a sterile product using microbiological growth medium instead of actual drug. If bacterial growth is detected after incubation, the personnel member has failed and cannot compound sterile preparations until retraining is complete and a passing media fill is achieved.

USP <795>: Nonsterile Compounding Personnel Requirements

The revised USP <795> formalized training requirements for nonsterile compounding personnel, an area that was historically less regulated. Personnel must demonstrate competency in: interpreting and following master formulation records and compounding records, performing accurate calculations (including unit conversions and concentration adjustments), selecting appropriate equipment and ingredients, applying proper compounding techniques for the dosage form (e.g., trituration, geometric dilution, levigation), and implementing quality control measures such as weight variation checks and pH testing. While media fill testing is not required for nonsterile compounding, the Designated Person must verify competency through direct observation, written assessments, and review of compounding records.

USP <800>: Hazardous Drug Compounding

Personnel who compound hazardous drugs (HDs) must meet all applicable requirements under USP <795> or <797> plus additional training mandated by USP <800>. This includes competency in the use of closed-system transfer devices (CSTDs), proper handling and disposal of HD waste, spill containment procedures, appropriate use of personal protective equipment (PPE) such as chemotherapy gloves and gowns, and decontamination and deactivation protocols. Training must be documented initially and repeated at least every 12 months.

⚠

State Board Variation — MPJE Alert

While USP standards establish the national floor for competency requirements, individual state boards of pharmacy may impose additional or more stringent requirements. For example, some states require specific continuing education hours in compounding, mandate additional competency evaluations beyond USP minimums, or require pharmacist-in-charge sign-off on all competency records. On the MPJE, always apply the most stringent applicable standard — if state law exceeds USP requirements, the state law controls.

SECTION 5

Detailed Breakdown — Competency Assessment Methods

Different compounding categories require different assessment methods, and each method serves a distinct purpose in verifying personnel readiness. The following table and diagram summarize the principal competency assessment tools recognized under USP standards, their application domains, and their reassessment frequencies.

Assessment Method	Applicable USP Chapter	What It Evaluates	Reassessment Frequency
Media Fill Test	USP <797>	Aseptic technique during sterile compounding; detects microbial contamination introduced by the compounder	Initially, then every 6 months (Category 1) or 6 months (Category 2)
Gloved Fingertip & Thumb Sampling (GFTS)	USP <797>	Effectiveness of hand hygiene and garbing; detects microbial contamination on gloved hands	Initially (×3 consecutive passes), then every 6 months
Direct Observation	USP <795>, <797>, <800>	Real-time assessment of technique, adherence to SOPs, and proper use of equipment and PPE	Initially, then every 12 months
Written Assessment	USP <795>, <797>, <800>	Knowledge of compounding principles, calculations, safety procedures, and regulatory requirements	Initially, then every 12 months
Spill Management Drill	USP <800>	Ability to safely contain, clean, and dispose of hazardous drug spills; proper donning of protective equipment	Initially, then every 12 months

Summary of principal competency assessment methods across USP chapters

Comparison of competency assessment requirements across the three major compounding categories. Note that hazardous drug compounding requires all assessments from the applicable base chapter (USP <795> or <797>) plus additional HD-specific competencies under USP <800>.

A critical point for MPJE preparation is understanding the initial GFTS requirement: personnel must pass three consecutive, separate gloved fingertip and thumb sampling tests before being authorized to compound sterile preparations independently. This is more rigorous than most other initial assessments and reflects the higher risk profile of sterile compounding. A single failed GFTS attempt means the entire sequence must restart after remediation.

SECTION 6

Worked Example — Implementing a Competency Training Program

Consider the following scenario: A community pharmacy has just installed a laminar airflow workbench and plans to begin offering Category 1 sterile compounding services. The pharmacist-in-charge (who is also the Designated Person) must establish a competency training program for a new pharmacy technician, Alex, who has never compounded sterile preparations before.

Setting Up Alex's Competency Training Program

1
Step 1 — Identify Applicable Standards

Because the pharmacy will perform Category 1 sterile compounding, the Designated Person must ensure Alex's training complies with USP <797> requirements. The DP also consults the state board of pharmacy regulations to identify any additional state-specific requirements (e.g., mandatory continuing education hours, additional documentation elements). Since the pharmacy does not compound hazardous drugs, USP <800> does not apply at this time.

Applicable standard: USP <797> + state pharmacy practice act
2
Step 2 — Complete Didactic Training

Before Alex touches any compounding equipment, the DP provides comprehensive didactic training covering: SOPs for hand hygiene and garbing, aseptic technique principles, proper use of the laminar airflow workbench (LAFW), cleaning and disinfection procedures, the pharmacy's master formulation records, and beyond-use dating guidelines for Category 1 CSPs. Alex must also review the pharmacy's quality assurance plan. The DP documents the date, duration, topics covered, and Alex's acknowledgment of completion.

Didactic training completed and documented with date and topics
3
Step 3 — Conduct Practical (Hands-On) Training

The DP supervises Alex performing each compounding procedure under direct observation. Alex practices proper hand washing technique (≥30 seconds with appropriate antimicrobial soap), correct garbing sequence (shoe covers, hair cover, face mask, hand washing, sterile gown, then sterile gloves), and aseptic manipulations within the LAFW. The DP corrects errors in real time and documents each training session.

Practical skills demonstrated under direct observation
4
Step 4 — Perform Initial Competency Assessments

Alex must pass three critical assessments: (a) a written examination on compounding knowledge, (b) three consecutive successful gloved fingertip and thumb sampling (GFTS) tests showing 0 colony-forming units (CFU) per hand, and (c) a media fill test in which a sterile growth medium is compounded using aseptic technique and incubated for 14 days — no turbidity (microbial growth) is an acceptable result. If Alex fails any single GFTS attempt, the sequence of three consecutive passes must restart from the beginning after retraining.

All three assessments passed: written exam, 3× GFTS (0 CFU each), media fill (no growth)
5
Step 5 — Document and Authorize

The DP creates a competency record for Alex that includes: all training dates and content, assessment dates and results (including incubation start/end dates for media fills), the DP's signature and credentials, and the date Alex is authorized to compound independently. This record is filed in the pharmacy's quality assurance documentation and must be available for state board inspection. The DP also notes in the record that Alex's next reassessment is due within 6 months for GFTS and media fill testing.

Alex authorized to compound Category 1 CSPs; reassessment due in 6 months

SECTION 7

Comparing Competency Requirements: Nonsterile vs. Sterile vs. Hazardous Drug

Understanding the differences and overlaps among competency requirements across compounding categories is frequently tested on the MPJE. The following table provides a side-by-side comparison that highlights the escalating rigor as the risk profile of the compounded preparation increases.

Requirement Element	Nonsterile (USP <795>)	Sterile (USP <797>)	Hazardous Drug (USP <800>)
Didactic Training	Required	Required	Required (HD-specific)
Practical Training	Required	Required	Required (HD-specific PPE & CSTDs)
Media Fill Test	Not required	Required	Required if sterile HD compounding
GFTS	Not required	Required (3× initial)	Required if sterile HD compounding
Spill Management Drill	Not required	Not required	Required
Reassessment Interval	Every 12 months	Every 6 months (media fill & GFTS)	Every 12 months (HD-specific)
Documentation	Required	Required	Required

Comparative competency requirements across USP compounding chapters

✦

KEY TAKEAWAY

Think of the competency requirements as a tiered security system. Nonsterile compounding is like a standard home security system — it provides baseline protection with alarms and locks (written assessments, direct observation). Sterile compounding is like a hospital-grade clean room access system — it adds biometric verification (media fill, GFTS) because the consequences of a breach are far more severe. Hazardous drug compounding adds a HAZMAT layer on top of whichever base system applies, requiring additional specialized training for the unique dangers involved. The MPJE expects you to identify which tier applies and what specific assessments that tier demands.

SECTION 8

Connection to Advanced Regulatory Concepts

Compounding competency training does not exist in isolation — it connects to broader regulatory frameworks that the MPJE tests across multiple content domains. Understanding these connections allows you to answer questions that integrate competency requirements with other aspects of pharmacy law and practice.

Related Concept	Connection to Competency Training
Quality Assurance (QA) Programs	Competency records are a required component of the pharmacy's overall QA program. Failed assessments trigger corrective and preventive actions (CAPAs) within the QA framework.
Section 503A vs. 503B Facilities	503A pharmacies follow state board oversight and USP standards. 503B outsourcing facilities are registered with the FDA and must follow current good manufacturing practices (cGMPs), which impose even more rigorous personnel qualification requirements.
Pharmacy Technician Scope of Practice	State laws define whether and to what extent pharmacy technicians may perform compounding tasks. Competency training does not expand a technician's legal scope of practice — they must be both legally authorized and demonstrably competent.
Board of Pharmacy Inspections	State board inspectors routinely review competency training records during pharmacy inspections. Deficiencies in documentation are among the most commonly cited violations, potentially resulting in fines, required corrective action plans, or license suspension.
Pharmacist Liability and Negligence	If a patient is harmed by a compounded preparation and the pharmacy cannot produce competency records for the personnel who compounded it, this creates strong evidence of negligence in civil litigation and may support disciplinary action by the state board.

How competency training connects to other MPJE content domains

As pharmacy practice continues to evolve, emerging areas such as office-use compounding (preparations compounded for a prescriber's office without patient-specific prescriptions), veterinary compounding, and compounding for clinical trials are generating new discussions about how competency requirements should be adapted. State boards are increasingly aligning their rules with USP standards while adding jurisdiction-specific requirements. For MPJE success, remain alert to the principle that federal standards set the minimum baseline, but state law always prevails when it is more stringent.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A pharmacy prepares nonsterile compounded preparations under USP <795>. A new pharmacy technician completes didactic training and a written examination but has not yet been directly observed compounding by the Designated Person. Can this technician independently compound nonsterile preparations? Explain your reasoning.

Show answer

No, the technician cannot compound independently. Under USP <795>, all compounding personnel must demonstrate competency through multiple methods, including direct observation of their technique by the Designated Person. A written examination alone verifies knowledge but does not confirm that the technician can correctly execute compounding procedures in practice. The DP must observe the technician performing actual compounding tasks, verify that proper technique is followed, and document the successful assessment before the technician is authorized to compound without direct supervision. Allowing the technician to compound without completing all required assessments would place the pharmacy in violation of USP <795> and potentially expose it to state board disciplinary action.

Question 2: BASIC CALCULATION

A pharmacy has 8 employees who perform sterile compounding. Under USP <797>, gloved fingertip and thumb sampling (GFTS) and media fill testing must be repeated every 6 months. How many total GFTS and media fill assessments must the Designated Person schedule over a 24-month period for all sterile compounding personnel (assuming no personnel changes and no failures requiring re-testing)?

Show answer

Each of the 8 employees requires reassessment every 6 months, which means 4 reassessment cycles occur within a 24-month period (at months 6, 12, 18, and 24). Note that we are counting reassessments only — initial competency assessments were already completed before the 24-month period began. For GFTS: 8 employees × 4 cycles = 32 GFTS assessments. For media fill testing: 8 employees × 4 cycles = 32 media fill tests. The total number of individual assessments is 32 + 32 = 64 assessments over 24 months. This calculation underscores the significant administrative burden of maintaining sterile compounding competency records, which is why many pharmacies use electronic tracking systems to ensure no reassessments are missed.

Question 3: INTERMEDIATE

A pharmacy technician at a hospital pharmacy successfully passes her first and second gloved fingertip and thumb sampling (GFTS) tests with 0 CFU per hand. On her third GFTS attempt, the results show 2 CFU on the right hand. What must happen next under USP <797> before this technician can compound sterile preparations independently?

Show answer

The technician has failed to meet the USP <797> initial GFTS requirement, which demands three consecutive successful samplings with 0 CFU on each hand. The single failure on the third attempt invalidates the entire sequence. The Designated Person must first investigate the potential cause of the failure (e.g., improper hand hygiene, glove contamination, breach in garbing technique) and document the findings. The technician must then undergo remedial training focused on the identified deficiency — in this case, likely re-education and practice on hand hygiene and sterile gloving technique. After retraining, the technician must restart the entire sequence of three consecutive GFTS tests from the beginning (not merely repeat the third test). Only after achieving three new consecutive passes with 0 CFU per hand will the technician be eligible for authorization. Throughout this process, the technician may not compound sterile preparations independently. All retraining and reassessment activities must be documented in the technician's competency file.

Question 4: APPLIED

A state board of pharmacy inspector visits a compounding pharmacy and discovers the following: (1) The pharmacy compounds both nonsterile and Category 1 sterile preparations. (2) One pharmacy technician's most recent media fill test was performed 9 months ago. (3) The same technician's competency training file contains no documentation of initial GFTS testing. (4) The Designated Person states that GFTS was performed but the results were not recorded. Identify all violations and explain what corrective actions the pharmacy must take.

Show answer

Multiple violations exist. First, the media fill test is overdue: USP <797> requires media fill reassessment every 6 months, and 9 months have elapsed since the last test, meaning the technician has been compounding without current competency verification for approximately 3 months. The technician should have been removed from sterile compounding duties when the 6-month deadline passed. Second, the absence of documented GFTS results is a serious documentation violation. Even if GFTS was performed as the DP claims, undocumented assessments are treated as if they never occurred for regulatory purposes. Without records showing three consecutive initial GFTS passes, there is no evidence that the technician was ever properly qualified to compound sterile preparations. Corrective actions required include: (a) immediately removing the technician from sterile compounding duties, (b) conducting new initial GFTS testing (three consecutive passes) and a new media fill test with proper documentation, (c) reviewing all compounding records for preparations made by this technician to assess potential quality concerns, (d) implementing a corrective and preventive action (CAPA) plan to prevent future documentation lapses, and (e) submitting a corrective action report to the state board if required by state regulation. The pharmacy may also face fines or other disciplinary measures from the state board.

Question 5: CRITICAL THINKING

A pharmacy currently compounds only nonsterile preparations under USP <795>. The pharmacy owner wants to begin compounding sterile hazardous drug preparations (e.g., compounded chemotherapy agents). Construct a comprehensive outline of the competency training program that the Designated Person must develop before any personnel can begin compounding these preparations. Address all applicable USP chapters and explain why each element is necessary.

Show answer

This scenario triggers requirements from three USP chapters: <797> (sterile compounding), <800> (hazardous drugs), and elements of <795> (baseline compounding knowledge). The competency training program must include the following components, each serving a distinct patient and worker safety function. First, didactic training must cover: aseptic technique theory and USP <797> standards (to prevent microbial contamination of sterile preparations), hazardous drug classification and the NIOSH list (to identify which drugs require HD precautions), proper use of negative-pressure containment primary engineering controls such as biological safety cabinets (BSCs) or compounding aseptic containment isolators (CACIs) required by USP <800>, closed-system transfer device (CSTD) operation (to prevent aerosolization and exposure), HD-specific PPE requirements including double chemotherapy gloves, impervious gowns, eye protection, and respiratory protection as indicated, spill containment and decontamination procedures (to protect personnel and the environment), and HD waste handling and disposal regulations. Second, practical training must include supervised practice in: donning and doffing HD-specific PPE in the correct sequence, aseptic compounding technique within the BSC or CACI, CSTD assembly and use, spill kit deployment, decontamination of work surfaces (using appropriate agents such as sodium hypochlorite followed by sodium thiosulfate neutralization), and proper segregation and disposal of HD waste. Third, competency assessments must include: written examination covering all didactic content, three consecutive successful GFTS tests (0 CFU per hand) as required by USP <797>, successful media fill test with 14-day incubation, direct observation of aseptic technique within the containment PEC, direct observation of proper PPE donning/doffing, and successful completion of a spill management drill as required by USP <800>. Fourth, documentation must record: every training session with date, content, trainer credentials, and trainee acknowledgment; all assessment dates, results, assessor identity, and pass/fail determinations; any failed assessments with root cause analysis and remediation plan; the authorization date for each employee to compound sterile HDs; and scheduled reassessment dates (every 6 months for GFTS and media fill, every 12 months for HD-specific competencies). Each element is necessary because sterile HD compounding carries dual risks — microbial contamination can harm patients, and HD exposure can harm compounding personnel — requiring the most comprehensive competency program in pharmacy practice.

SUMMARY

Lesson Summary

Summary

Compounding competency training is a legally mandated, cyclical process that applies to all personnel involved in any aspect of pharmacy compounding. The Designated Person oversees the entire program, which consists of didactic training, practical (hands-on) training, and formal competency assessments that vary by compounding category. Nonsterile compounding (USP <795>) requires written assessments and direct observation with annual reassessment. Sterile compounding (USP <797>) adds media fill testing and gloved fingertip and thumb sampling (GFTS) — including three consecutive initial passes — with reassessment every six months. Hazardous drug compounding (USP <800>) layers additional requirements for PPE competency, spill management drills, and CSTD use on top of the applicable base chapter.

Every training activity and assessment result must be documented and maintained for state board inspection, and personnel who fail any assessment must undergo retraining and successful reassessment before resuming compounding. For the MPJE, remember that USP standards establish the national minimum, but state law prevails when it is more stringent. Competency training is not merely a regulatory checkbox — it is the primary mechanism through which pharmacies ensure that every compounded preparation meets the quality standards necessary to protect patient safety.